Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.230
+0.010 (0.82%)
At close: Aug 13, 2026, 4:00 PM EDT
1.210
-0.020 (-1.63%)
After-hours: Aug 13, 2026, 7:45 PM EDT

Metagenomi Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4661135---
Market Cap Growth
-32.08%-54.88%----
Enterprise Value
-36.48-59.2-67.45000
Last Close Price
1.231.623.61---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.452.422.58---
PB Ratio
0.410.380.58---
P/TBV Ratio
0.410.380.51---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--2.35-1.29---
EV/EBITDA Ratio
-0.650.81---
EV/EBIT Ratio
-0.620.76---
EV/FCF Ratio
-0.660.60---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.280.220.170.210.061.10
Debt / FCF Ratio
----1.182.29
Net Debt / Equity Ratio
-0.74-0.76-0.861.644.621.82
Net Debt / EBITDA Ratio
0.871.332.433.008.012.51
Net Debt / FCF Ratio
0.971.341.812.20-21.82-2.77
Asset Turnover
0.070.090.150.110.060.00
Quick Ratio
4.377.026.693.977.494.30
Current Ratio
4.507.226.914.047.564.33
Return on Equity (ROE)
-68.93%-44.67%-34.69%-28.04%-27.62%-48.79%
Return on Assets (ROA)
-50.84%-35.17%-24.09%-22.83%-17.05%-16.86%
Return on Invested Capital (ROIC)
-302.15%-271.11%-676.50%---
Return on Capital Employed (ROCE)
-58.43%-39.56%-30.48%-23.72%-18.49%-20.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-1.07%-12.79%-870.10%-0.15%0.15%-
Total Shareholder Return
-1.07%-12.79%-870.10%-0.15%0.15%-
SEC Filings: 10-K · 10-Q